Transverse coloplasty vs. side-to-end anastomosis following low anterior resection (LAR)

Not Applicable

Recruiting

• Conditions: C20; Malignant neoplasm of rectum

• Registration Number: DRKS00026594
• Lead Sponsor: Klinik für Allgemein-, Viszeral- und Transplantationschirurgie LMU, Klinikum der Universität München Campus Großhadern

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-09-09
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

elective LAR for Patient suffering from rectal Cancer and planned anasomosis location in middle and distal third of the rectum - local curative therapy - normal preoperativ continence - sphincter preserving surgery available - non-IBD-associated carcinomas - informed consent

Exclusion Criteria

non curative therapy - emergency surgery in case of tumor perforation, sepsis, abscess - proximal rectal carcinomas (located >12 cm from dentate line) - no informed consent - age < 18 years - reduced or lack of legal capacity to contract - inclusion in other studies with interfering endpoint - live expectancy < 24 months - pregnancy - immunosuppression

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
stool frequency/24h 6 months after LAR

Secondary Outcome Measures

Name	Time	Method
Quality of life, continency, postoperative complications following LAR